--- title: FidoCure blog | Case Studies (2) description: Case Studies | Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates. (2) --- [![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/) - [Veterinarians](https://fidocure.com/for-veterinarians/) - [Portal Login](https://dvm.fidocure.com/) - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet) - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies) - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars) - [Pet Parents](https://fidocure.com/pet-parents/) - [About Us](https://fidocure.com/about-us/) - [How it works](https://fidocure.com/how-it-works/) - [Find a Clinic](https://fidocure.com/find-a-clinic/) - [Contact Us](https://fidocure.com/contact-us/) # FidoCure Veterinary Team Blog ### Read the latest in veterinary oncology research and FidoCure scientific and clinical updates from our team of experts and advisors Select Category Case Studies Press Vet Webinars This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. Posts about: ## Case Studies (2) ![](https://blog.fidocure.com/hubfs/sam.jpg) ### [Splenic Hemangiosarcoma Case Study: Sam](https://blog.fidocure.com/fidocure-blog/splenic-hemangiosarcoma-case-study-sam) #### After FidoCure**®** enabled treatment, Sam exceeded the 5-7  month median survival time for splenic hemangiosarcoma by living over one year beyond diagnosis. [Read More](https://blog.fidocure.com/fidocure-blog/splenic-hemangiosarcoma-case-study-sam) ![](https://blog.fidocure.com/hubfs/heidi.jpg) ### [Mesothelioma Case Study: Heidi](https://blog.fidocure.com/fidocure-blog/mesothelioma-case-study-heidi) #### With combination therapy that included targeted therapy guided by  FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong. [Read More](https://blog.fidocure.com/fidocure-blog/mesothelioma-case-study-heidi) ![](https://blog.fidocure.com/hubfs/scout.jpg) ### [Telangiectatic Osteosarcoma Case Study: Scout](https://blog.fidocure.com/fidocure-blog/telangiectatic-osteosarcoma-case-study-scout) #### With a combination approach that included FidoCure® therapy, Scout has lived for 1.5 years after his initial diagnosis of telangiectatic osteosarcoma. [Read More](https://blog.fidocure.com/fidocure-blog/telangiectatic-osteosarcoma-case-study-scout) ![](https://blog.fidocure.com/hubfs/Brady.jpg) ### [Anal Sac Adenocarcinoma Case Study: Brady](https://blog.fidocure.com/fidocure-blog/anal-sac-adenocarcinoma-case-study-brady) [Read More](https://blog.fidocure.com/fidocure-blog/anal-sac-adenocarcinoma-case-study-brady) ![](https://blog.fidocure.com/hubfs/Ruby.jpg) ### [Transitional Cell Carcinoma Case Study: Ruby](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby) #### With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma. [Read More](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby) ![](https://blog.fidocure.com/hubfs/phinn.jpg) ### [Amelanotic Melanoma Case Study: Phinn](https://blog.fidocure.com/fidocure-blog/amelanotic-melanoma-case-study-phinn) #### With the help of FidoCure® therapy, Phinn has lived a great quality of life for over 18 months after his initial diagnosis of amelanotic melanoma and is still going strong! [Read More](https://blog.fidocure.com/fidocure-blog/amelanotic-melanoma-case-study-phinn) ![](https://blog.fidocure.com/hubfs/IMG_1085-1.jpg) ### [Jejunal Adenocarcinoma Case Study: Callie](https://blog.fidocure.com/fidocure-blog/fidocure-r-case-study-callie-augur) #### With surgery and FidoCure® therapy, Callie is alive and well almost 20 months after her initial diagnosis of jejunal adenocarcinoma. [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-r-case-study-callie-augur) ![](https://blog.fidocure.com/hubfs/Jade.jpg) ### [Osteosarcoma Case Study: Jade](https://blog.fidocure.com/fidocure-blog/osteosarcoma-case-study-jade-joseph) #### With a combination approach that included FidoCure® therapy, Jade is alive and well 2 years after her initial diagnosis of osteosarcoma. [Read More](https://blog.fidocure.com/fidocure-blog/osteosarcoma-case-study-jade-joseph) ![](https://blog.fidocure.com/hubfs/winston.jpg) ### [Insulinoma Case Study: Winston](https://blog.fidocure.com/fidocure-blog/metastic-insulinoma) #### With a combination approach that included FidoCure®, Winston survived two years following his initial diagnosis of metastatic insulinoma. [Read More](https://blog.fidocure.com/fidocure-blog/metastic-insulinoma) [1](https://blog.fidocure.com/fidocure-blog/tag/case-studies) [2](https://blog.fidocure.com/fidocure-blog/tag/case-studies/page/2) ![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg) - [How it Works](https://fidocure.com/how-it-works/) - [FAQ](https://fidocure.com/faq/) - [Contact Us](https://fidocurestg.wpengine.com/contact-us/) - [For Vets](https://fidocure.com/for-veterinarians/) - [About Us](https://fidocure.com/about-us/) - [Terms of Service](https://fidocure.com/terms-of-service/) - [Blog](https://blog.fidocure.com/fidocure-blog) - [Careers](https://fidocure.com/careers/) - [Privacy Policy](https://fidocure.com/privacy-policy/) - - - - **FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.  © Copyright 2018-2026 One Health Company, All rights reserved